Aurora Cannabis Inc logo

Aurora Cannabis Inc (21P1)

Market Closed
5 Dec, 20:00
XFRA XFRA
3. 90
0
0%
211.07M Market Cap
- P/E Ratio
0% Div Yield
42 Volume
-0.1 Eps
3.9
Previous Close
Day Range
3.9 3.9
Year Range
3.31 6.65
Want to track 21P1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

21P1 closed yesterday higher at €3.9, an increase of 0% from Thursday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 21P1 stock lost -3.82%.
21P1 is not paying dividends to its shareholders.
The last earnings report, released on Feb 06, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Aurora Cannabis Inc has completed 1 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

21P1 Chart

Similar

9F9
Elektro Importoren AS
1.13
+0.89%
0CD
Canatu Oy
7.92
0%
1NL
VRG S.A.
1.16
+0.43%
5G7
KB Components AB
3.77
-1.7%
9N0
Litalico Inc.
-
-

Aurora Cannabis Inc (21P1) FAQ

What is the stock price today?

The current price is €3.90.

On which exchange is it traded?

Aurora Cannabis Inc is listed on XFRA.

What is its stock symbol?

The ticker symbol is 21P1.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 211.07M.

Has Aurora Cannabis Inc ever had a stock split?

Aurora Cannabis Inc had 1 splits and the recent split was on Feb 20, 2024.

Aurora Cannabis Inc Profile

Specialty Retail Industry
Consumer Discretionary Sector
Miguel Martin CEO
XFRA Exchange
- CUSIP
CA Country
1,073 Employees
- Last Dividend
20 Feb 2024 Last Split
11 Jul 2014 IPO Date

Overview

Aurora Cannabis Inc. is a leader in the global cannabis industry, engaging in the production, distribution, and sale of cannabis and its derivatives across Canada and international markets. The company operates through three core segments: Canadian Cannabis, European Cannabis, and Plant Propagation. Its strategies include not only addressing the medical and consumer cannabis markets in Canada but also distributing wholesale medical cannabis throughout the European Union, various international regions such as Australia, the Caribbean, South America, and Israel, and providing supply for propagated vegetables and ornamental plants in North America. Furthermore, Aurora Cannabis extends its presence into the distribution and sale of hemp-derived CBD products. Based in Edmonton, Canada, the company has carved out a competitive position in the global landscape by focusing on diverse product offerings and comprehensive patient counseling and outreach services.

Products and Services

  • Dried Cannabis, Cannabis Oils, and Capsules

    Aurora Cannabis produces a range of consumables including dried cannabis, cannabis oils, and capsules. These products are designed for multiple modes of consumption such as smoking, vaporizing, or ingestion in oil, capsule, or edible form. Each method offers a distinctive experience tailored to consumer and medical patient preferences.

  • Edible Cannabis, Extracts, and Soft Gels

    The company's portfolio includes edible cannabis products, extracts, and soft gels. These products provide alternatives for those preferring not to inhale their cannabis, offering a variety of potencies and formulas to suit a diverse client base with specific needs.

  • Recreational Cannabis Products

    Aurora's recreational cannabis products span categories such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products. These offerings fall under brands like Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, enabling Aurora to cater to a broad range of consumer tastes and preferences.

  • Medical Cannabis Brands

    With a focus on patient needs, Aurora offers medical cannabis products under brands such as MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. These products are developed to support patients with specific therapeutic needs, ensuring high quality and efficacy.

  • Hemp-derived CBD Products

    Aurora distributes and sells a variety of hemp-derived CBD products, including brands like Reliva and KG7. These products cater to the growing demand for non-psychoactive cannabinoid products, offering benefits without the high associated with THC.

  • Patient Counseling and Outreach Services

    Beyond physical products, Aurora Cannabis extends its services to include patient counseling and outreach. This service demonstrates Aurora's commitment to the well-being of its customers, providing valuable information, support, and guidance on the use of cannabis for medical purposes.

Contact Information

Address: 500 - 10355 Jasper Avenue
Phone: 16043625207